By Frederick R. Ball and Victoria (Tori) Hawekotte
Attorneys from Duane Morris’ Life Sciences and Medical Technologies Industry Group attended the Food & Drug Law Institute’s Annual Conference, which featured participation from senior leadership at the Food and Drug Administration. Former FDA Commissioner Martin Makary highlighted the agency’s aim to decrease time to decision on applications and increase efficiency of reviews. He also discussed the trend of research and manufacturing moving internationally and potential reforms to make domestic manufacturing and research more feasible.